LeMaitre Vascular, Inc. Completes Enrollment In EndoFit Clinical Study In China

... LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today the enrollment of the 30th and final patient in the EndoFit Thoracic Stent Graft Clinical Study in China. The objective of this study, which commenced in August 2006, is to obtain clinical data in support of approval of the EndoFit Thoracic Stent Graft from the Chinese State Food and Drug Administration (SFDA). [click link for full article] ...